Neuron Bio S.A. | Cash Flow
Fiscal year is January-December. All values EUR Thousands.
2012
2013
2014
2015
2016
Net Income before Extraordinaries
630.40
2,097.70
2,982.10
169.40
4,940.40
Depreciation, Depletion & Amortization
1,666.70
1,748.60
1,553.10
1,418.20
3,233.80
Other Funds
977.40
582.40
423.80
337.40
1,407.20
Funds from Operations
896.80
1,085.50
1,926.20
960.10
695.00
Changes in Working Capital
274.90
1,139.30
842.90
658.90
655.00
Net Operating Cash Flow
1,171.70
53.80
2,769.10
301.20
40.00
Capital Expenditures
3,487.50
4,031.70
688.00
1,361.80
2,300.80
Sale of Fixed Assets & Businesses
-
-
-
300.00
1.50
Purchase/Sale of Investments
1,999.90
114.00
116.70
-
485.30
Net Investing Cash Flow
1,326.70
4,145.70
571.30
745.90
2,784.60
Issuance/Reduction of Debt, Net
1,373.10
2,693.80
337.20
1,371.60
559.50
Net Financing Cash Flow
2,366.50
3,450.90
3,566.50
1,011.20
3,177.40
Net Change in Cash
131.90
641.00
226.00
35.90
360.80
Free Cash Flow
2,642.80
2,511.10
2,811.90
649.70
187.00
Net Assets from Acquisitions
-
-
-
2.50
-
Other Sources
160.90
-
-
496.30
-
Change in Capital Stock
16.00
174.70
2,805.50
2,045.50
4,025.10
Exchange Rate Effect
0.00
-
0.00
0.00
8.00
Other Uses
-
-
-
177.90
-
About Neuron Bio
View Profile
